Advertisement
Canada markets close in 41 minutes
  • S&P/TSX

    22,211.64
    +104.56 (+0.47%)
     
  • S&P 500

    5,261.47
    +12.98 (+0.25%)
     
  • DOW

    39,830.52
    +70.44 (+0.18%)
     
  • CAD/USD

    0.7382
    +0.0010 (+0.13%)
     
  • CRUDE OIL

    83.09
    +1.74 (+2.14%)
     
  • Bitcoin CAD

    95,862.33
    +2,701.27 (+2.90%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,241.60
    +28.90 (+1.31%)
     
  • RUSSELL 2000

    2,124.79
    +10.44 (+0.49%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • NASDAQ

    16,403.81
    +4.29 (+0.03%)
     
  • VOLATILITY

    12.90
    +0.12 (+0.94%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • CAD/EUR

    0.6841
    +0.0036 (+0.53%)
     

IMS Health Holdings Makes a Strong Debut on the NYSE; Halozyme Therapeutics Temporarily Suspends Phase 2 PEGPH20 Trials

IMS Health Holdings, Inc. (NYSE:IMS - News) – For an in-depth report on IMS Health Holdings, Inc. Corporation follow: www.BullTrends.com/stockquote/IMS

IMS Health Holdings closed up 15% on about 33.2 million shares traded. The stock was one of the biggest gainers on the NYSE. The stock made its trading debut that day on the NYSE and Bloomberg reported that the company and its investors managed to raise $1.3 billion after selling the stock for $20 a share.

Halozyme Therapeutics, Inc. (NASDAQ:HALO - News) - For an in-depth report on Halozyme Therapeutics, Inc. follow: www.BullTrends.com/stockquote/HALO

Shares of HALO closed down 27.26% on Friday with about 20 million shares traded. The stock was one of the biggest decliners on the NASDAQ. The company announced that it would temporarily suspend enrollment in an ongoing Phase 2 trial of its PEGPH20 treatment of patients with pancreatic cancer. The company said it would take "precautionary actions" in response to an independent data monitoring committee's suggestion on Thursday.

ADVERTISEMENT

Baidu, Inc. (NASDAQ:BIDU - News) - For an in-depth report on Baidu, Inc. follow: www.BullTrends.com/stockquote/BIDU

Shares of BIDU closed down 5.14% on about 8.2 million shares traded. The stock was one of the biggest decliners on the NASDAQ. The company has argued a U.S. lawsuit filed by pro-democracy activists. The plaintiffs had alleged that censorship by the website at the behest of China’s government was in violation of rights as ensured by the First Amendment. However, according to the decision made by U.S. District Court Judge Jesse Furman: "The First Amendment protects Baidu's right to advocate for systems of government other than democracy (in China or elsewhere) just as surely as it protects plaintiffs' rights to advocate for democracy."

Ehouse Global, Inc. (OTCBB:EHOS - News) – For an in-depth report on Ehouse Global, Inc. follow: www.BullTrends.com/stockquote/EHOS

Shares of EHOS closed up 48.65% on about 19 million shares traded. The stock was one of the biggest gainers in the OTCBB market. The company had no significant news to explain the breakout. EHouse Global is a publicly traded company on the OTCBB Market stock exchange under the ticker symbol EHOS. Headquartered in La Jolla, CA, EHouse Global acquires, develops and sells leading edge consumer oriented products ready for rapid commercialization.

Disclosure: BullTrends.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.